The present invention relates to novel compounds of formula (I) suitable e.g. as therapeutic agents for use in the treatment of mammalian disease and in particular to novel therapeutic agents suitable for use in the treatment of microbial infection in mammals. The present invention further relates to the use of pharmaceutical compositions comprising said agents in the treatment of medical conditions in mammals, in particular in the treatment of microbial infection. The agents and pharmaceutical compositions of the invention are of particular relevance in the treatment of diseases associated with antibiotic-resistant microbes. The present invention also relates to processes for making said agents.
本发明涉及一种新型化合物,其
化学式为(I),适用于作为治疗剂用于治疗哺乳动物疾病,特别是适用于治疗哺乳动物微
生物感染的新型治疗剂。本发明还涉及包含所述治疗剂的药物组合物在治疗哺乳动物的医疗状况中的使用,特别是在治疗微
生物感染方面的使用。本发明的治疗剂和药物组合物在治疗与
抗生素耐药微
生物相关的疾病方面具有特殊的相关性。本发明还涉及制备所述治疗剂的方法。